- Home
- TPCS vs CRIS Comparison
TPCS vs CRIS Comparison
Compare TPCS & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPCS
- CRIS
- Stock Information
- Founded
- TPCS 1956
- CRIS 2000
- Country
- TPCS United States
- CRIS United States
- Employees
- TPCS N/A
- CRIS N/A
- Industry
- TPCS Metal Fabrications
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TPCS Industrials
- CRIS Health Care
- Exchange
- TPCS Nasdaq
- CRIS Nasdaq
- Market Cap
- TPCS 51.4M
- CRIS 22.9M
- IPO Year
- TPCS N/A
- CRIS 2000
- Fundamental
- Price
- TPCS $5.44
- CRIS $1.67
- Analyst Decision
- TPCS
- CRIS Strong Buy
- Analyst Count
- TPCS 0
- CRIS 2
- Target Price
- TPCS N/A
- CRIS $16.50
- AVG Volume (30 Days)
- TPCS 59.0K
- CRIS 76.7K
- Earning Date
- TPCS 08-21-2025
- CRIS 11-13-2025
- Dividend Yield
- TPCS N/A
- CRIS N/A
- EPS Growth
- TPCS N/A
- CRIS N/A
- EPS
- TPCS N/A
- CRIS N/A
- Revenue
- TPCS $33,424,000.00
- CRIS $11,405,000.00
- Revenue This Year
- TPCS N/A
- CRIS $1.41
- Revenue Next Year
- TPCS N/A
- CRIS $7.46
- P/E Ratio
- TPCS N/A
- CRIS N/A
- Revenue Growth
- TPCS 3.78
- CRIS 12.24
- 52 Week Low
- TPCS $2.05
- CRIS $1.02
- 52 Week High
- TPCS $6.25
- CRIS $6.44
- Technical
- Relative Strength Index (RSI)
- TPCS 54.95
- CRIS 45.61
- Support Level
- TPCS $5.26
- CRIS $1.63
- Resistance Level
- TPCS $5.50
- CRIS $1.95
- Average True Range (ATR)
- TPCS 0.26
- CRIS 0.15
- MACD
- TPCS -0.04
- CRIS 0.00
- Stochastic Oscillator
- TPCS 46.53
- CRIS 17.65
About TPCS TechPrecision Corporation Common stock
Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components. It derives maximum revenue from Ranor segment.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.